Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Development of Diffusion MRI and Tractography Technique for the Detection of Nerve Lesions in Brachial Plexus Injuries (IRM-POPB)

11 de agosto de 2026 actualizado por: Assistance Publique - Hôpitaux de Paris

Development of Diffusion MRI and Tractography Technique for the Detection of Nerve Lesions in Brachial Plexus Injuries: Feasibility Study

The objective of this prospective study is to contribute to improving the management of patients with obstetric brachial plexus palsy.

The main objective is the characterization of the microstructure by diffusion MRI in patients with a history of unoperated obstetrical brachial plexus palsy.

Descripción general del estudio

Estado

Reclutamiento

Intervención / Tratamiento

Descripción detallada

The brachial plexus is a collection of nerve fibers that provides all sensory and motor functions of the entire upper limb. Its anatomy is particularly complex.

Obstetric brachial plexus palsy (OBP) is defined as flaccid paralysis of the upper limb, occurring at birth, related to forceful manipulation of the fetus for its delivery. This neonatal condition is not uncommon.

While most cases of OBP appear to recover spontaneously, children with incomplete recovery may have significant functional limitations related to muscle weakness, more or less associated with soft tissue retractions. Muscle weakness will induce an imbalance that can affect bone growth and joint development.

Simple stretching or neurapraxia almost always progresses spontaneously and favorably. Avulsion injuries, on the other hand, cannot heal spontaneously and therefore require surgery to restore upper limb function. The aim of this study is that DTI (Diffusion Tensor Imaging) imaging of the brachial plexus allows access to the entire brachial plexus in order to establish a lesion assessment and a powerful tool to aid in the decision for surgical exploration.

To date, there is no standard imaging technique for exploring the brachial plexus.

Diffusion tensor imaging is a new acquisition technique that tracks the movement of water molecules in all three spatial planes.

Tractography, or fiber tracking, is an acquisition and analysis technique performed using diffusion tensor imaging (DTI) MRI data.

An MRI protocol has been developed for analyzing the brachial plexus based on pilot MRI scans performed at the Brain and Spine Institute. Subjects selected for this study will undergo MRI scans using different sequences from this protocol. Image processing and tractography sequences will allow for precise analysis of the function and structure of the brachial plexus nerves and characterization of lesions in affected subjects compared to the unaffected contralateral side. The hypothesis of this research is that DTI imaging of the brachial plexus will allow a better understanding of POPB by establishing a precise lesion assessment in association with clinical data.

This is a single-center, non-randomized feasibility study involving MRI imaging analyses and requiring no changes to the patient's usual care.

Imaging data from each subject will be analyzed and statistically compared. Each patient will serve as their own control (comparison between the healthy and pathological plexus).

Imaging data from each subject can be analyzed and statistically compared.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

8

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Manon BACHY-RAZZOUK, PU-PH
  • Número de teléfono: 00 33 1 44 73 69 37
  • Correo electrónico: manon.bachy@aphp.fr

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

      • Paris, Francia, 75012
        • Reclutamiento
        • Service de Chirurgie Orthopédique et Réparatrice de l'Enfant, Hôpital Armand Trousseau AP-HP
        • Contacto:
          • Manon BACCHY-RAZZOUK, PU-PH
          • Número de teléfono: 00 33 1 44 73 69 37
          • Correo electrónico: manon.bachy@aphp.fr
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Patients aged 14 to 30 years
  • Consulted by the Orthopedics Department at Armand Trousseau Hospital
  • Diagnosed and monitored by Armand Trousseau Hospital for obstetrical brachial plexus palsy (OBBP)
  • Having a single, unoperated lesion (lesions are very different and only exceptionally affect all the roots bilaterally).
  • Not suffering from bone or neurological pathology unrelated to OBP
  • Patients affiliated with or entitled to a social security scheme
  • Patients who have received informed information and have signed, with the investigator, a consent form to participate in the study
  • Parents/legal guardians who have received informed information and have co-signed, with the investigator, a consent form to participate in the study, for minor patients

Exclusion Criteria:

  • History of rheumatoid pathologies, constitutional bone diseases, past or current pathologies affecting the arm or neck unrelated to the obstetric brachial plexus, any history of neoplasia or radiographic appearance consistent with a neoplastic fracture
  • Current pregnancy
  • Inability to perform the MRI examination (presence of a contraindication, incapacitating pain, or claustrophobia)
  • Large tattoo present in the area of interest (artifacts)
  • Patients deprived of liberty, or under guardianship/curatorship
  • Patients receiving medical assistance (AME)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Otro: One group

Various MRI sequences were performed (without injection) according to a new protocol developed at the ICM.

This acquisition protocol consists of anatomical and diffusion sequences lasting approximately 1 hour.

The acquisitions were performed in a 3T MRI scanner, in the supine position with the palms facing upwards. Gadolinium was not used in our study.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Characterization of the microstructure by MRI diffusion in patients with a history of unoperated obstetrical brachial plexus palsy (OBBP)
Periodo de tiempo: 3 months max.
Extraction of diffusion tensor parameters (measurement of signal anisotropy ) along the different nerves constituting the brachial plexus, reconstructed using tractography.
3 months max.
Characterization of the microstructure by MRI diffusion in patients with a history of unoperated obstetrical brachial plexus palsy (OBBP)
Periodo de tiempo: 3 months max.
Extraction of diffusion tensor parameters, measurement of diffusivity, along the different nerves constituting the brachial plexus, reconstructed using tractography
3 months max.
Characterization of the microstructure by MRI diffusion in patients with a history of unoperated obstetrical brachial plexus palsy (OBBP)
Periodo de tiempo: 3 months max.
Comparison of metrics (Anitropy Fraction, Mean Diffusion) of healthy versus injured nerves. Each plexus is manually segmented by ITK SNAP in order to extract the nerve pathways of each plexus.
3 months max.
Characterization of the microstructure by MRI diffusion in patients with a history of unoperated obstetrical brachial plexus palsy (OBBP)
Periodo de tiempo: 3 months max.
Description of FA, MD parameter measurements on tractography sequences along the complete pathway of the brachial plexus nerves
3 months max.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Determination of the anatomical location of POPB lesions (trunk, terminal branches, etc.) in comparison with the contralateral healthy side of the patients
Periodo de tiempo: 3 months max.
Compare by MRI diffusion anatomical and diffusion measurements between different subjects
3 months max.
Analyze the plexus fibers altered by the neuroma in the affected plexuses
Periodo de tiempo: 3 months max.
Analysis of the qualitative characteristics of the axons studied in the plexus area of the neuroma in affected subjects (visual analysis of the roots affected by the neuroma compared with the healthy side, as well as measurement of the volumes in voxels)
3 months max.
Analyze the plexus fibers altered by the neuroma in the affected plexuses
Periodo de tiempo: 3 months max.
Analysis of the quantitative characteristics of the axons studied in the plexus area of the neuroma in affected subjects (fractional anisotropy, mean diffusion, axial diffusion and radial diffusion)
3 months max.
Establish anatomoclinical relationships with the data from the specific and in-depth clinical examination carried out in consultation
Periodo de tiempo: 3 months max.
Analysis of the apparent lesions visible on MRI
3 months max.
Analyze the feasibility of the DTI MRI acquisition protocol
Periodo de tiempo: 3 months max.
Feasibility : acquisition time (the acquisition time required to obtain image quality sufficient for post-MRI analysis),
3 months max.
Analyze the feasibility of the DTI MRI acquisition protocol
Periodo de tiempo: 3 months max.
Feasibility: imaging quality
3 months max.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Manon BACHY-RAZZOUK, PU-PH, Assistance Publique - Hôpitaux de Paris

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

9 de enero de 2026

Finalización primaria (Estimado)

1 de enero de 2027

Finalización del estudio (Estimado)

1 de febrero de 2027

Fechas de registro del estudio

Enviado por primera vez

24 de junio de 2025

Primero enviado que cumplió con los criterios de control de calidad

11 de agosto de 2026

Publicado por primera vez (Actual)

17 de agosto de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de agosto de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

11 de agosto de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • APHP211551
  • IDRCB: 2024-A02069-38 (Otro identificador: ANSM)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir